These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 15577164
1. [Right or wrong of the hormone replacement therapy involving osteoporosis]. Hoshino S, Ouchi Y. Clin Calcium; 2004 Nov; 14(11):87-98. PubMed ID: 15577164 [Abstract] [Full Text] [Related]
3. Hormone replacement therapy in postmenopausal women. Yasui T, Uemura H, Takikawa M, Irahara M. J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382 [Abstract] [Full Text] [Related]
4. Postmenopausal osteoporosis and hormone replacement therapy. Gambacciani M, Vacca F. Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435 [Abstract] [Full Text] [Related]
5. [Estrogen replacement therapy: for whom, why and how?]. Rozenberg S, Neusy S, Barudy J, Fellemans C, Jahjah L. Rev Med Brux; 2002 Sep; 23(4):A382-9. PubMed ID: 12422465 [Abstract] [Full Text] [Related]
6. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis. Levine JP. Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027 [Abstract] [Full Text] [Related]
7. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy. Popp AW, Bodmer C, Senn C, Fuchs G, Kraenzlin ME, Wyss H, Birkhaeuser MH, Lippuner K. Maturitas; 2006 Jan 20; 53(2):191-200. PubMed ID: 16368472 [Abstract] [Full Text] [Related]
8. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Skouby SO, Al-Azzawi F, Barlow D, Calaf-Alsina Erdogan Ertüngealp J, Gompel A, Graziottin A, Hudita D, Pines A, Rozenberg S, Samsioe G, Stevenson JC, European Menopause and Andropause Society. Maturitas; 2005 May 16; 51(1):8-14. PubMed ID: 15883103 [Abstract] [Full Text] [Related]
9. [Evidence of hormone replacement therapy for osteoporosis]. Tarakida A, Higuchi T, Mizunuma H. Clin Calcium; 2008 Oct 16; 18(10):1434-41. PubMed ID: 18830040 [Abstract] [Full Text] [Related]
10. Justification for the use of HRT in the long-term prevention of osteoporosis. Stevenson JC. Maturitas; 2005 Jun 16; 51(2):113-26. PubMed ID: 15917151 [Abstract] [Full Text] [Related]
11. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women]. Gorai I, World Health Organization. Clin Calcium; 2007 Jul 16; 17(7):1090-6. PubMed ID: 17607077 [Abstract] [Full Text] [Related]
12. Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis. Kung AW, Chu EY, Xu L. Expert Opin Pharmacother; 2009 Jun 16; 10(8):1377-85. PubMed ID: 19445558 [Abstract] [Full Text] [Related]
13. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT. Morishige K, Yamamoto T, Sawada K, Ohmichi M, Tasaka K, Murata Y. Arch Gynecol Obstet; 2003 Jun 16; 268(2):105-6. PubMed ID: 12768299 [Abstract] [Full Text] [Related]
14. Low-dose hormone replacement therapy: effects on bone. Gambacciani M, Monteleone P, Genazzani AR. Climacteric; 2002 Jun 16; 5(2):135-9. PubMed ID: 12051108 [Abstract] [Full Text] [Related]
15. Hormone replacement therapy: what is the evidence today? Uebelhart B, Frey D, Uebelhart D. Z Rheumatol; 2003 Dec 16; 62(6):508-11. PubMed ID: 14685710 [Abstract] [Full Text] [Related]
16. [Alternatives to hormone replacement therapy: raloxifene and tibolone]. von Holst T. Z Arztl Fortbild Qualitatssich; 2000 Apr 16; 94(3):205-9. PubMed ID: 10802895 [Abstract] [Full Text] [Related]
17. Hormone replacement therapy: to use or not to use? Baber RJ, O'Hara JL, Boyle FM. Med J Aust; 2003 Jun 16; 178(12):630-3. PubMed ID: 12797851 [Abstract] [Full Text] [Related]
18. [Biochemical markers of bone turnover. New aspect. Effects of androgen and estrogen on biochemical markers of bone turnover]. Ohnaka K, Takayanagi R. Clin Calcium; 2009 Aug 16; 19(8):1118-24. PubMed ID: 19638695 [Abstract] [Full Text] [Related]
19. [Some problems of postmenopausal osteoporosis prevention with hormone replacement therapy]. Liu JL. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun 16; 25(3):240-3. PubMed ID: 12905731 [Abstract] [Full Text] [Related]
20. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy. Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C. J Endocrinol Invest; 2005 Jun 16; 28(10 Suppl):80-4. PubMed ID: 16550729 [Abstract] [Full Text] [Related] Page: [Next] [New Search]